ERBB2 and neoplasm: Of the ALDH1-positive tumours, 31% were of the luminal subtype (27.3% luminal A, 3.4% luminal B), 31% had a basal-like subtype (core basal phenotype; BLP4), 16% were in the HER2 subtype and 23% were in the unclassified category.